CA procedure than after RFA; however, the patients
in both groups had had similar QoL scores at 1 and
2 years. In the LAMA (randomized controlled trial of
endovenous laser ablation versus mechanochemical
ablation with ClariVein in the management of superÔ¨Åcial
venous incompetence) trial, 150 patients had been randomized to EVLA or the MOCA procedure. Similar low
intraprocedural pain scores